Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Cited by (1,003)

Items 901–1,000 of 1,003

1. Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing PI3K/Akt/Bad cascade via regulating PTEN
   Yingwei Zhu, Hong Tang, Lili Zhang, Lei Gong, Gaojue Wu, Jingbin Ni, Xuejun Tang · 2019 · Cancer Management and Research
2. Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA
   Nina‐Beate Liabakk, Anders Sundan, SVERRE HELGE TORP, Pål Aukrust, Stig Sophus Frøland, Terje Espevik · 2002 · Journal of Immunological Methods
3. Glycosylation modulates TRAIL-R1/death receptor 4 protein: different regulations of two pro-apoptotic receptors for TRAIL by tunicamycin
   Tatsushi Yoshida, Takumi Shiraishi, Mano Horinaka, Miki Wakada, Toshiyuki Sakai · 2007 · Oncology Reports
4. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8
   Larisa L. Belyanskaya, Algirdas Ziogas, Sally Hopkins-Donaldson, Stefanie Kurtz, Hans‐Uwe Simon, Rolf Arno Stahel, Uwe Zangemeister‐Wittke · 2008 · Lung Cancer
5. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer
   Constantine S. Mitsiades, Vassiliki Poulaki, Nicholas Mitsiades · 2003 · Journal of Endocrinology
6. Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line
   Malabika Sarker, Carmen Ruiz‐Ruiz, Abelardo López‐Rivas · 2001 · Cell Death and Differentiation
7. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth
   Boqiang Hu, L Kou, Chao Li, L-P Zhu, Y-R Fan, Z-W Wu, J-J Wang, G-X Xu · 2009 · Cancer Gene Therapy
8. Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors
   Toshihiko Doi, Haruyasu Murakami, Atsushi Ohtsu, Nozomu Fuse, Takayuki Yoshino, Nobuyuki Yamamoto, Narikazu Boku, Yusuke Onozawa, C-P. Hsu, Kevin S. Gorski et al. · 2010 · Cancer Chemotherapy and Pharmacology
9. TRAIL/TRAIL‐R in hematologic malignancies
   Ugo Testa · 2010 · Journal of Cellular Biochemistry
10. Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect
    Ja Young Seol, Kyungho Park, Chang‐Il Hwang, Woong‐Yang Park, Chul‐Gyu Yoo, Young Whan Kim, Sung Koo Han, Young‐Soo Shim, Choon‐Taek Lee · 2003 · Cancer Gene Therapy
11. Stem cells are resistant to TRAIL receptor‐mediated apoptosis
    Éva Szegezdi, Aoife O’Reilly, Davy Yeung, Reaz Vawda, Deanna L. Taylor, Mary J. Murphy, Afshin Samali A, Huseyin Mehmet · 2008 · Journal of Cellular and Molecular Medicine
12. Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response
    Lihua Chen, Chen Chen Jiang, Kelly A. Avery‐Kiejda, Yufang Wang, Rick Francis Thorne, Xu Dong Zhang, Peter Hersey · 2007 · Carcinogenesis
13. Acquired resistance to TRAIL-induced apoptosis in human ovarian cancer cells is conferred by increased turnover of mature caspase-3
    Denis A. Lane, Marceline Côté, Roxanne Grondin, Marie-Christine Couture, Alain Piché · 2006 · Molecular Cancer Therapeutics
14. Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance
    Steven A. Maxwell, Seyed Mousavi-Fard · 2013 · Experimental Biology and Medicine
15. Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy
    Xu Wu, Shengpeng Wang, Mingxing Li, Anqi Wang, Yangyang Y. Zhou, Peng Li, Yitao Wang · 2017 · Nanoscale
16. Oxidative stress-driven DR5 upregulation restores TRAIL/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer
    Yesi Shi, Junqing Wang, Jingyi Liu, Gan Lin, Fengfei Xie, Xin Pang, Yihua Pei, Yi Cheng, Yang Zhang, Zhong‐Ning Lin et al. · 2019 · Biomaterials
17. Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
    Ryoichi Tanaka, Mitsuhiro Tomosugi, Mano Horinaka, Yoshihiro Sowa, Toshiyuki Sakai · 2015 · PLoS ONE
18. Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand and Its Receptor Expression and the Pathway of Apoptosis in Human Pancreatic Cancer
    Kennichi Satoh, Kenzo Kaneko, Morihisa Hirota, Atsushi Masamune, Akihiko Satoh, Tooru Shimosegawa · 2001 · Pancreas
19. Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction
    Antonello Petrella, Simona Francesca Ercolino, Michela Festa, Antonio Gentilella, Alessandra Tosco, Suzanne Daniela Conzen, Luca Parente · 2006 · European Journal of Cancer
20. cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis
    Maria Eugenia Guicciardi, Steven F. Bronk, Nathan W. Werneburg, Gregory James Gores · 2007 · American Journal of Physiology-Gastrointestinal and Liver Physiology
21. The involvement of oxidative stress in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in HeLa cells
    Myoung Woo Lee, Soon Cheol Park, Joung‐Hun Kim, InKi Kim, Kun Soo Han, Kyung Yong Kim, Won Bok Lee, Yong‐Keun Jung, Sung Soo Kim · 2002 · Cancer Letters
22. Novel biological therapies for the treatment of multiple myeloma
    Paul Gerard Guy Richardson, Constantine S. Mitsiades, Teru Hideshima, Kenneth Carl Anderson · 2005 · Best Practice & Research Clinical Haematology
23. A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents
    Y Arizono, Hideshi Yoshikawa, Hirofumi Naganuma, Yoshio Hamada, Y Nakajima, Keiji Tasaka · 2003 · British Journal of Cancer
24. Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors
    Hong Xiang, Judith Ann Fox, Klára Tótpál, Mina Aikawa, Kelly DuPree, Dominick V. Sinicropi, John R. Lowe, Enrique Escandón · 2002 · Oncogene
25. Kaempferol: A potential agent in the prevention of colorectal cancer
    Hamid Reza Nejabati, Leila Roshangar · 2022 · Physiological Reports
26. Therapeutic targeting of TRAIL death receptors
    Francesca Di Cristofano, Andrew George, Vida Tajiknia, Maryam Ghandali, Laura Jinxuan Wu, Yiqun Zhang, Praveen R. Srinivasan, Jillian Strandberg, Marina Hahn, Ashley Sanchez Sevilla Uruchurtu et al. · 2023 · Biochemical Society Transactions
27. Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐induced chemokine release in both TRAIL‐resistant and TRAIL‐sensitive cells via nuclear factor kappa B
    Wanhu Tang, Weimin Wang, Yaxi Zhang, Shilian Liu, Yanxin Liu, Dexian Zheng · 2008 · FEBS Journal
28. TRAIL‐Induced Apoptosis
    Nadia Corazza, Daniela Kassahn, Sabine Jakob, Anastasia Badmann, Thomas Brunner · 2009 · Annals of the New York Academy of Sciences
29. Overcoming Acquired Resistance to TRAIL by Chemotherapeutic Agents and Calpain Inhibitor I through Distinct Mechanisms
    Hongbo Zhu, Lidong Zhang, Xuefeng Huang, John J Davis, Dietmar Jacob, Fuminori Teraishi, Paul J. Chiao, Bingliang Fang · 2004 · Molecular Therapy
30. Targeting PDGFR ‐β in Cholangiocarcinoma
    Christian Dominik Fingas, Joachim C. Mertens, Nataliya Razumilava, Steven F. Bronk, Alphonse Eugene Sirica, Gregory James Gores · 2011 · Liver International
31. Expression, Cellular Distribution, and Prognostic Relevance of TRAIL Receptors in Hepatocellular Carcinoma
    Lydia Kriegl, Andreas Jung, Jutta Engel, René Jackstadt, Alexander L. Gerbes, Eike Gallmeier, Jana A. Reiche, Heiko Hermeking, Antonia Rizzani, Christiane J. Bruns et al. · 2010 · Clinical Cancer Research
32. Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid
    S Schneider-Jakob, Nadia Corazza, Anastasia Badmann, Daniel Sidler, Regula Stuber Roos, Adrian Keogh, Steffen Frese, Mario P. Tschan, Thomas Brunner · 2010 · Cell Death and Disease
33. Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage
    Hyeonseok Ko, Mi‐Hyeon Jeong, Hyelin Jeon, Gi‐Jun Sung, Youngsin So, InKi Kim, Jaekyoung Son, Sang-wook Lee, Ho‐Geun Yoon, Kyung‐Chul Choi · 2015 · Oncotarget
34. Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer
    Claudia Geismann, Frauke Grohmann, Anita Dreher, Robert Häsler, Philip C Rosenstiel, Karen Legler, Charlotte Hauser, Jan Hendrik Egberts, Bence Sipos, Stefan Schreiber et al. · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
35. CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors
    Clemens Reinshagen, Deepak Bhere, Sung Hugh Choi, Stefan J. Hutten, Irina Nesterenko, Hiroaki Wakimoto, Eloi Le Roux, Alia Rizvi, Wanlu Du, Charles Minicucci et al. · 2018 · Science Translational Medicine
36. Blockade of Death Receptor-Mediated Pathways Early in the Signaling Cascade Coincides with Distinct Apoptosis Resistance in Cutaneous T-Cell Lymphoma Cells
    Frank Braun, Lothar F. Fecker, Constanze Schwarz, Peter Walden, Chalid Assaf, Horst Dürkop, Wolfram Sterry, Jürgen Eberle · 2007 · Journal of Investigative Dermatology
37. Following the TRAIL to Apoptosis
    Bharti R. Chaudhari, Richard F. Murphy, Devendra K. Agrawal · 2006 · Immunologic Research
38. Sulindac sulfide–induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2
    Frank A. Sinicrope, Robert C. Penington · 2005 · Molecular Cancer Therapeutics
39. Trail Receptor-Targeted Therapy
    Donald J. Buchsbaum, Tong Zhou, Albert F. LoBuglio · 2006 · Future Oncology
40. eNOS protects prostate cancer cells from TRAIL-induced apoptosis
    Xin Tong, Honglin Li · 2004 · Cancer Letters
41. Mesenchymal Progenitors Expressing<scp>TRAIL</scp>Induce Apoptosis in Sarcomas
    Grisendi, Giulia, Spano, Carlotta, D'souza, Naomi, Rasini, Valeria, Veronesi, Elena, Prapa, Malvina, Petrachi, Tiziana, Piccinno, Serena, Rossignoli, Filippo, Burns, Jorge S. et al. · 2015 · STEM CELLS
42. Detection of soluble TRAIL in HBV infected patients and its clinical implications
    Lihui Han · 2002 · World Journal of Gastroenterology
43. Roles of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling Pathway in Granulosa Cell Apoptosis During Atresia in Pig Ovaries
    Naoko Inoue, Noboru MANABE, Toshikatsu Matsui, Akihisa Maeda, Shinsuke NAKAGAWA, Satoko Wada, Hajime MIYAMOTO · 2003 · Journal of Reproduction and Development
44. Caspase-8 as a Regulator of Tumor Cell Motility
    Ryon P. Graf, N. Keller, Simone Barbero, Dwayne G. Stupack · 2014 · Current Molecular Medicine
45. Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter
    Cihui Yan, Ming Yang, Zhenzhen Li, Shuangjing Li, Xiao Hu, Dongmei Fan, Yanjun Zhang, Jianxiang Wang, Dongsheng Xiong · 2014 · Biomaterials
46. Increased Apoptosis Induction in Hepatocellular Carcinoma by a Novel Tumor-Targeted TRAIL Fusion Protein Combined With Bortezomib
    Kristin Wahl, Martin Siegemund, Frank Lehner, Florian W. R. Vondran, Andreas Klaus Nussler, Florian Peter Länger, Till Krech, Roland E. Kontermann, Michael Peter Manns, Klaus Schulze‐Osthoff et al. · 2012 · Hepatology
47. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway
    Xiaoqing Guo, Yue Meng, Xiaotong Sheng, Yuan Guan, Fenglei Zhang, Zhen Hai Han, Yuying Kang, Guihua Tai, Yifa Zhou, Hairong Cheng · 2016 · Anti-Cancer Drugs
48. The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia
    Raedeh Saraei, Masoud Soleimani, Ali Akbar Movassaghpour Akbari, Majid Farshdousti Hagh, Ali Hassanzadeh, Saeed Solali · 2018 · Biomedicine & Pharmacotherapy
49. Death Receptor Ligands, in Particular TRAIL, to Overcome Drug Resistance
    Steven de Jong, Tineke Timmer, Frank J. Heijenbrok, Elisabeth G.E. de Vries · 2001 · Cancer and Metastasis Reviews
50. Enhanced Metastasis Suppression by Targeting TRAIL Receptor 2 in a Murine Model of Triple-Negative Breast Cancer
    Dmitry Malin, Feng Chen, Carol L. Schiller, Jennifer E. Koblinski, Vincent L. Cryns · 2011 · Clinical Cancer Research
51. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model
    John Michael Straughn, Patsy G. Oliver, Tong Zhou, Wenquan Wang, Ronald David Alvarez, William E. Grizzle, Donald J. Buchsbaum · 2005 · Gynecologic Oncology
52. Preferential Utilization of the Perforin/Granzyme Pathway for Lysis of Epstein–Barr Virus-Transformed Lymphoblastoid Cells by Virus-Specific CD4+ T Cells
    Aaruni Khanolkar, Hideo Yagita∥, Martin J. Cannon · 2001 · Virology
53. CELL DEATH AT THE MILLENNIUM
    Neil Kaplowitz · 2000 · Clinics in Liver Disease
54. Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response
    Piper A. Rawding, Jiyoon Bu, Jianxin Wang, DaWon Kim, Adam J. Drelich, Young Soo Kim, Seungpyo Hong · 2021 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
55. Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets
    Vincenza Barresi, Camillo Musmeci, Alessandro Rinaldi, D. F. Condorelli · 2022 · International Journal of Molecular Sciences
56. Hyaluronic acid–tumor necrosis factor-related apoptosis-inducing ligand conjugate for targeted treatment of liver fibrosis
    Jeong‐A Yang, Won Ho Kong, Dong Kyung Sung, Hyemin Kim, Tae Hyung Kim, Kang Choon Lee, Sei Kwang Hahn · 2014 · Acta Biomaterialia
57. Death receptor-4 (DR4) expression is regulated by transcription factor NF-κB in response to etoposide treatment
    Francisco J. Mendoza, Ganchimeg Ishdorj, Xiaojie Hu, Spencer Bruce Gibson · 2008 · APOPTOSIS
58. DAPK2 is a novel modulator of TRAIL-induced apoptosis
    C R Schlegel, A-V Fonseca, Sarah Stöcker, M L Georgiou, M B Misterek, C E Munro, Catarina Ramos do Carmo, Michael J. Seckl, Ana P. Costa‐Pereira · 2014 · Cell Death and Differentiation
59. Combined modality therapy with TRAIL or agonistic death receptor antibodies
    Hope M. Amm, Patsy G. Oliver, Choo Hyung Lee, Yufeng Li, Donald J. Buchsbaum · 2011 · Cancer Biology & Therapy
60. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins
    Lan Yang, Qiong Wang, Daoxia Li, Yuqiong Zhou, Xuelian Zheng, Hong Sun, Jiaqi Yan, Lin Zhang, Yong Lin, Xia Wang · 2013 · APOPTOSIS
61. Blockade of transforming growth factor-β-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade
    Min‐Kyung Choo, Noritaka Kawasaki, Pattama Singhirunnusorn, Keiichi Koizumi, Shintaro Sato, Shizuo Akira, Ikuo Saiki, Hiroaki Sakurai · 2006 · Molecular Cancer Therapeutics
62. Anti-Gout Agent Allopurinol Exerts Cytotoxicity to Human Hormone-Refractory Prostate Cancer Cells in Combination with Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand
    Takashi Yasuda, Tatsushi Yoshida, Ahmed E. Goda, Mano Horinaka, Kimihiro Yano, Takumi Shiraishi, Miki Wakada, Yoichi Mizutani, Tsuneharu Miki, Toshiyuki Sakai · 2008 · Molecular Cancer Research
63. Halocynthiaxanthin and Peridinin Sensitize Colon Cancer Cell Lines to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand
    Tatsushi Yoshida, Takashi Maoka, Swadesh Kumar Das, Kazuki Kanazawa, Mano Horinaka, Miki Wakada, Yoshiko Satomi, Hoyoku Nishino, Toshiyuki Sakai · 2007 · Molecular Cancer Research
64. Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
    Mohammed I. Y. Elmallah, Olivier Micheau · 2019 · Cancers
65. Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells
    Tatsushi Yoshida, Mano Horinaka, Mami Takara, Mayuko Tsuchihashi, Nobuhiro Mukai, Miki Wakada, Toshiyuki Sakai · 2008 · Environmental Health and Preventive Medicine
66. Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity
    Rebecca L. VanOosten, James K. Earel, Thomas S. Griffith · 2006 · APOPTOSIS
67. Pretreatment of indole‐3‐carbinol augments TRAIL‐induced apoptosis in a prostate cancer cell line, LNCaP
    Kye‐Im Jeon, Jeong-Keun Rih, Hee Jeong Kim, Yong Jun Lee, Chi‐Heum Cho, Itzhak D. Goldberg, Eliot M. Rosen, Insoo Bae · 2003 · FEBS Letters
68. Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer
    Stephan Wolf, Daniel Mertens, Armin Pscherer, Petra Schroeter, Dirk F. H. Winkler, Hermann‐Josef Gröne, Christof Hofele, Kari Hemminki, Rajiv Kumar, Gunnar Steineck et al. · 2005 · International Journal of Cancer
69. Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer
    Carmine Stolfi, Francesco Pallone, Giovanni Monteleone · 2012 · International Journal of Molecular Sciences
70. Caspase-10 Sensitizes Breast Carcinoma Cells to TRAIL-Induced but Not Tumor Necrosis Factor-Induced Apoptosis in a Caspase- 3-Dependent Manner
    Ingo H. Engels, Gudrun Totzke, Ute Fischer, Klaus Schulze‐Osthoff, Reiner U. Jänicke · 2005 · Molecular and Cellular Biology
71. Expression of Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand and Its Receptors in Rat Testis During Development
    Renée Grataroli, David Vindrieux, Alain Gougeon, Mohamed Benahmed · 2002 · Biology of Reproduction
72. Intra-articular injection of recombinant TRAIL induces synovial apoptosis and reduces inflammation in a rabbit knee model of arthritis
    Qingping Yao, Dai‐Wu Seol, Zhibao Mi, Paul D. Robbins · 2005 · Arthritis Research & Therapy
73. Signaling to gene activation and cell death by tumor necrosis factor receptors and fas
    Rudi Beyaert, Geert Loo, Karen Heyninck, Peter Vandenabeele · 2002 · International review of cytology
74. INVOLVEMENT OF TRAIL/TRAIL-R INTERACTION IN IFN-α-INDUCED APOPTOSIS OF DAUDI B LYMPHOMA CELLS
    Kazutaka Oshima, Noriko Yanase, Chiharu Ibukiyama, Akira Yamashina, Nobuhiko Kayagaki, Hideo Yagita∥, Junichiro Mizuguchi · 2001 · Cytokine
75. Expression and Function of Death Receptors and Their Natural Ligands in the Intestine
    Jörn Sträter, Peter Möller · 2000 · Annals of the New York Academy of Sciences
76. Regulation of Sensitivity to TRAIL by the PTEN Tumor Suppressor
    Young E. Whang, Xiu‐Juan Yuan, Yuanbo Liu, Samarpan Majumder, Terrence D. Lewis · 2004 · Vitamins and hormones
77. A synthetic lethal screen identifies FAT1 as an antagonist of caspase‐8 in extrinsic apoptosis
    Dominique Kranz, Michael Boutros · 2014 · The EMBO Journal
78. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand1
    Fang FANG, Aiping Wang, Shifang Yang · 2005 · Acta Pharmacologica Sinica
79. Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis
    Ian M. Sudbery, Anton James Enright, Andrew G. Fraser, Ian Dunham · 2010 · BMC Genomics
80. Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer
    Ufuk Mert, Ahter Dilşad Şanlioğlu · 2016 · Cellular and Molecular Life Sciences
81. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover
    Ji Hye Kim, Min Joo Kim, Kyung‐Chul Choi, Jaekyoung Son · 2016 · The International Journal of Biochemistry & Cell Biology
82. Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity
    Rebecca Voltan, Paola Secchiero, Fabio Casciano, Daniela Milani, Giorgio Zauli, Veronica Tisato · 2016 · The International Journal of Biochemistry & Cell Biology
83. Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells
    Anna Willms, Hella Schittek, Sascha Rahn, Justyna Sosna, Ufuk Mert, Dieter Adam, Anna Trauzold · 2019 · PLoS ONE
84. Countering TRAIL Resistance in Melanoma
    Jürgen Eberle · 2019 · Cancers
85. Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest
    Songqing He, Hasibur Rehman, Ming-guang Gong, Yong-Zhong Zhao, Zhiyong Huang, Changhai Li, Wanguang Zhang, Xiaoping Chen · 2007 · Cancer Biology & Therapy
86. Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Death of Thyroid Cancer Cells
    Zhen‐Xian Du, Hua‐Qin Wang, Hai-Yan Zhang, Da-Xin Gao · 2007 · Endocrinology
87. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
    Tasanee Panichakul, Pakamas Intachote, Adisak Wongkajorsilp, Banchob Sripa, Stitaya Sirisinha · 2006 · PubMed
88. TRAIL and Chemotherapeutic Drugs in Cancer Therapy
    Xiu‐Xian Wu, Osamu Ogawa, Yoshiyuki Kakehi · 2004 · Vitamins and hormones
89. Pharmacokinetics and Immunological Effects of Exogenously Administered Recombinant Human B Lymphocyte Stimulator (BLyS) in Mice
    Tom J. Parry, Todd A. Riccobene, Steven J. Strawn, Rita Williams, Rami Daoud, Jeffrey A. Carrell, Svetlana Sosnovtseva, Renée C. Miceli, Carol Poortman, Les Sekut et al. · 2001 · Journal of Pharmacology and Experimental Therapeutics
90. Genetic Information, Genomic Technologies, and the Future of Drug Discovery
    Thomas F. Bumol · 2001 · JAMA
91. TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
    Hojjat Alizadeh Zeinabad, Éva Szegezdi · 2022 · Cancers
92. Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells
    Shenglong Xia, Zimo Liu, Jieru Cai, Huiming Ren, Qi Li, Hongfang Zhang, Yue Jing, Quan Zhou, Tianhua Zhou, Liangjing Wang et al. · 2023 · Journal of Controlled Release
93. Effect of β-Phenylethyl Isothiocyanate from Cruciferous Vegetables on Growth Inhibition and Apoptosis of Cervical Cancer Cells through the Induction of Death Receptors 4 and 5
    Le Diem Huong, Jung-Hyung Shim, Kyeong‐Hee Choi, Ji‐Ae Shin, Eun‐Sun Choi, Hyung‐Seop Kim, Sook-Jeong Lee, Sun‐Ju Kim, Nam‐Pyo Cho, Sung‐Dae Cho · 2011 · Journal of Agricultural and Food Chemistry
94. Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation with Hepatocellular Carcinoma
    Masahiro Ohira, Seigo Nishida, Panagiotis Tryphonopoulos, Akin Tekin, Gennaro Selvaggi, Jang Moon, David Levi, Camillo Ricordi, Kohei Ishiyama, Yuka Tanaka et al. · 2012 · Cell Transplantation
95. Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients
    Pavel P. Osmancik, Elena Teringová, Petr Toušek, Petra Paulů, Petr Widimský · 2013 · PLoS ONE
96. Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo
    Christian G. Huber, N Bobek, Jurgen H. E. Kuball, Sonja Thaler, Sandra Hoffarth, Christian G. Huber, Matthias Theobald, Martin Schüler · 2005 · Cell Death and Differentiation
97. TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
    Lingyi Fu, Ke Shi, Jingshu Wang, Wangbing Chen, Dingbo Shi, Yun Tian, Wei Guo, Wendan Yu, Xiangsheng Xiao, Tiebang Kang et al. · 2014 · Molecular Cancer
98. Preparation and Characterization of Apo2L/TNF-Related Apoptosis-Inducing Ligand–Loaded Human Serum Albumin Nanoparticles with Improved Stability and Tumor Distribution
    Tae Hyung Kim, Haihua Jiang, Yu Seok Youn, Chan Woong Park, Sung Mook Lim, Cheng‐Hao Jin, Kyung Kook Tak, Hye Suk Lee, Kang Choon Lee · 2010 · Journal of Pharmaceutical Sciences
99. Mitochondrial Transmembrane Potential and Reactive Oxygen Species Generation Regulate the Enhanced Effect of CCCP on TRAIL-Induced SNU-638 Cell Apoptosis
    CHAUDHARI, Atul A., SEOL, Jae-Won, KANG, Seog-Jin, PARK, Sang-Youel · 2008 · Journal of Veterinary Medical Science
100. hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma
     Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit · 2016 · Cell Death Discovery